Li Jinkai, Mei Jianhua, Yu Jie, Chen Xiaolei, Zhu Jianliang, Ye Jiaji, Zhang Deyong, Cheng Dongqing, Chen Xiuying
School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Lishui Center for Disease Control and Prevention, Lishui, 323000, China.
Virol J. 2025 Apr 19;22(1):111. doi: 10.1186/s12985-025-02734-6.
Transmitted drug resistance (TDR) is becoming an obstacle to the success of antiretroviral therapy (ART) as the HIV epidemic continues to spread. This study aimed to investigate the characteristics of TDR and the molecular epidemiology of ART-naive HIV-1 infections in Lishui.
A total of 481 plasma samples were collected from ART-naive HIV-1 infections in Lishui between 2020 and 2023. The sequences acquired from infections were used to analyze the characteristics of genotype, TDR, and molecular transmission network.
This study discovered that the three most prevalent subtypes among the 455 sequences successfully obtained from infections in Lishui were CRF08_BC (35.8%), CRF07_BC (26.4%), and CRF01_AE (25.9%). The overall prevalence of TDR was 12.1%, and the K103N (2.4%) was the most frequent mutation. Multivariate analysis showed that CRF08_BC (OR = 5.401, P < 0.001) and CD4 cell concentration of 200-499 cells/µL (OR = 1.684, P = 0.030) were associated with a higher risk of entering the molecular transmission network and clustering, whereas the current address in other cities (OR = 0.328, P = 0.004), junior middle school (OR = 0.472, P = 0.006), and junior college or above (OR = 0.387, P = 0.045) were associated with a lower risk of clustering.
This study revealed that the prevalence of TDR was at an intermediate level of drug resistance, and high levels of resistance were predominantly concentrated in efavirenz (EFV) and nevirapine (NVP) among the NNRTIs. Middle-aged and older infections represented a significant proportion of the molecular transmission network. This suggests that HIV surveillance and targeted prevention and treatment interventions are essential to reduce the risk of HIV transmission.
随着艾滋病疫情持续蔓延,传播耐药性(TDR)正成为抗逆转录病毒疗法(ART)取得成功的障碍。本研究旨在调查丽水市初治HIV-1感染者的TDR特征及分子流行病学情况。
2020年至2023年期间,共收集了481份来自丽水市初治HIV-1感染者的血浆样本。对感染获得的序列进行分析,以研究基因型、TDR特征及分子传播网络。
本研究发现,从丽水市感染者成功获得的455个序列中,三种最常见的亚型为CRF08_BC(35.8%)、CRF07_BC(26.4%)和CRF-01_AE(25.9%)。TDR的总体流行率为12.1%,最常见的突变是K103N(2.4%)。多因素分析显示,CRF08_BC(比值比[OR]=5.401,P<0.001)和CD4细胞浓度为200-499个细胞/微升(OR=1.684,P=0.030)与进入分子传播网络和聚类的较高风险相关,而在其他城市的现居地址(OR=0.328,P=0.004)、初中(OR=0.472,P=0.006)以及大专及以上学历(OR=0.387,P=0.045)与聚类的较低风险相关。
本研究表明,TDR的流行率处于耐药的中等水平,在非核苷类逆转录酶抑制剂中,高水平耐药主要集中在依非韦伦(EFV)和奈韦拉平(NVP)。中年及老年感染者在分子传播网络中占很大比例。这表明,艾滋病监测以及有针对性的预防和治疗干预对于降低艾滋病传播风险至关重要。